01.01.2015 Views

Cardiopulmonary Bypass in infants and children - Sha-conferences ...

Cardiopulmonary Bypass in infants and children - Sha-conferences ...

Cardiopulmonary Bypass in infants and children - Sha-conferences ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Cardiopulmonary</strong> <strong>Bypass</strong> <strong>in</strong><br />

<strong>in</strong>fants <strong>and</strong> <strong>children</strong><br />

The impact of prim<strong>in</strong>g solutions <strong>and</strong><br />

volumes<br />

Helen Holtby MB BS FRCPC<br />

Helen Holtby MB, BS FRCPC<br />

Hospital for Sick Children Toronto


The Ideal <strong>Cardiopulmonary</strong> <strong>Bypass</strong> Prime …<br />

<br />

<br />

<br />

<br />

Would be physiologic<br />

<br />

mild hypocalcemia<br />

Would not trigger:<br />

<strong>in</strong>flammation<br />

immune response<br />

Would prevent macro or microthrombosis<br />

Would protect end-organ function


Prime volumes <strong>in</strong> Pediatric Patients<br />

• Start at about 200-300ml generally<br />

• Circulat<strong>in</strong>g volume of neonates is 80ml/kg (240ml)<br />

• Dilution of RBC, platelets, coagulation factors<br />

• Dilution of plasma prote<strong>in</strong>s, drug levels<br />

• Significant electrolyte changes


Realistic Prime Solutions<br />

• At least physiologic:<br />

• Blood Prime:<br />

• Age of blood<br />

• Impact of Red Cell transfusions<br />

• Hematocrit values<br />

• Crystalloid/colloid Solutions:<br />

• Colloid osmotic pressure <strong>and</strong> outcomes<br />

• Small volume circuits


Blood Products <strong>and</strong><br />

<strong>Cardiopulmonary</strong> <strong>Bypass</strong><br />

• Age of RBCs <strong>and</strong> outcomes<br />

• Use of whole blood vs component products<br />

• Target hematocrit<br />

• Dilutional l Coagulopathy<br />

• Metabolic Consequences


Age of RBCs <strong>and</strong> Cl<strong>in</strong>ical Effects<br />

<strong>in</strong> Pediatric i Patients<br />

t<br />

• Keidan I,et al . The metabolic effects of fresh versus old stored<br />

blood <strong>in</strong> the prim<strong>in</strong>g of cardiopulmonary bypass solution for pediatric<br />

patients. J Thorac Cardiovasc Surg. 2004 Apr;127(4):949-52.<br />

• Schroeder TH, Hansen M. Effects of fresh versus old stored blood <strong>in</strong><br />

the prim<strong>in</strong>g solution on whole blood lactate levels dur<strong>in</strong>g paediatric<br />

cardiac surgery. Perfusion. 2005 Jan;20(1):17-9.<br />

• Gruenwald CE,et al. Reconstituted fresh whole blood improves<br />

cl<strong>in</strong>ical outcomes compared with stored component blood therapy<br />

for neonates undergo<strong>in</strong>g cardiopulmonary bypass for cardiac surgery:<br />

a r<strong>and</strong>omized controlled trial. J Thorac Cardiovasc Surg. 2008<br />

Dec;136(6):1442-9.<br />

• Ranucci M, et al. Duration of red blood cell storage <strong>and</strong> outcomes <strong>in</strong><br />

pediatric cardiac surgery: an association found for pump prime<br />

blood. Crit Care. 2009;13(6):R207. Epub 2009 Dec 21.


Studies of Blood Products,Bleed<strong>in</strong>g <strong>and</strong><br />

Outcomes Are Confounded By:<br />

• Storage Solutions<br />

• Leucocyte Depletion<br />

• Legislation<br />

• Transfusion Protocols <strong>and</strong> adherence<br />

• Surrogate end po<strong>in</strong>ts <strong>and</strong> relevant f<strong>in</strong>d<strong>in</strong>gs<br />

• Lactate dur<strong>in</strong>g CPB<br />

• Def<strong>in</strong>ition of old vs new


Reconstituted Fresh Whole Blood vs Stored<br />

Blood Component Therapy for Neonates<br />

Undergo<strong>in</strong>g Cardiac Surgery<br />

Study Design<br />

♥ s<strong>in</strong>gle center, prospective RCT<br />

♥ Entrance criteria :<br />

• neonates less than one month of age undergo<strong>in</strong>g CPB for elective open<br />

heart surgery<br />

♥ Exclusion criteria:<br />

• emergency surgery<br />

• known pre-exist<strong>in</strong>g coagulopathy


Study Protocol<br />

Treatment Group<br />

Reconstituted Fresh Whole Blood<br />

(RFWB)<br />

Control Group<br />

Component Blood<br />

Therapy<br />

CPB Prime<br />

• RFWB to achieve<br />

HCT 22-24% on CPB<br />

• RBC to achieve<br />

HCT 22-24% on CPB<br />

Dur<strong>in</strong>g CPB<br />

• RFWB to achieve<br />

HCT >28% prior to term<strong>in</strong>ation<br />

i<br />

of CPB<br />

• 1 unit FFP prior to cross<br />

clamp removal<br />

• RBC to achieve<br />

HCT >28% prior to<br />

term<strong>in</strong>ation of CPB


Conclusions<br />

RFWB is associated with improved cl<strong>in</strong>ical outcomes:<br />

reduced d d chest tube loss at 24 hours <strong>in</strong> CCCU<br />

reduced markers of systemic <strong>in</strong>flammation<br />

reduced ventilation time<br />

reduced <strong>in</strong>otropic support at 24 hours<br />

reduced hospital LOS<br />

It is unclear if this is a result of age of product or<br />

donor exposures or both or someth<strong>in</strong>g else entirely!


Independent effect on post-operative operative outcomes<br />

Chest tube loss 24 hours<br />

Lower platelet count), p


Outcomes <strong>and</strong> Storage of RBCs<br />

• Retrospective review of 192 <strong>children</strong><br />

• Centrifugal pump<br />

• Older blood >4 days<br />

• Results<br />

• Risk of major morbidity only if blood prime<br />

• Increased risk of postoperative complications<br />

• Pulmonary<br />

• Renal<br />

Ranucci M, et al.


Hemostatic Consequences of<br />

Blood Prime<br />

• 30 patients


Results<br />

• No difference between whole blood <strong>and</strong> component<br />

therapy<br />

• Significant thrombocytopenia<br />

• Significant reduction <strong>in</strong>:<br />

• Fibr<strong>in</strong>ogen<br />

• AT III<br />

• Plasm<strong>in</strong>ogen<br />

• II, V, VII, VIII, X<br />

Fibr<strong>in</strong>ogen


Maybe Fresh Whole Blood<br />

• Less <strong>in</strong>flammation i <strong>and</strong> less bleed<strong>in</strong>g<br />

• 200 patients


Results<br />

• Fresh whole blood has no advantage over component<br />

therapy<br />

• In fact…<br />

• Increased LOS <strong>in</strong> CCU<br />

• Increased perioperative fluid overload<br />

• Fewer (by one!) donor exposures


Maybe No Blood<br />

• Limits i of hemodilution<br />

i • Hematocrit<br />

• Dilutional Coagulopathy<br />

• Thrombocytopenia


Hematocrit<br />

• Newburger JW, et al. R<strong>and</strong>omized trial of hematocrit 25%<br />

versus 35% dur<strong>in</strong>g hypothermic cardiopulmonary bypass <strong>in</strong><br />

<strong>in</strong>fant heart surgery. J Thorac Cardiovasc Surg. 2008<br />

Feb;135(2):347-54, 354.e1-4.<br />

No difference between Hct 25% <strong>and</strong> 35%<br />

• Wypij D, et al.J Thorac Cardiovasc Surg. 2008 Feb;135(2):347-<br />

54, 354.e1-4. A hematocrit level at the onset of low-flow<br />

cardiopulmonary bypass of approximately 24% or higher is<br />

associated with higher Psychomotor Development Index<br />

scores <strong>and</strong> reduced lactate levels…..<br />

This study cannot ascerta<strong>in</strong> a universally "safe” hemodilution.


Asangu<strong>in</strong>ous Prime<br />

• Is Beneficial fiil • Is Ahi Achievable<br />

• Less <strong>in</strong>flammation<br />

• Less blood transfusion<br />

• Similar outcomes<br />

• 120-200mL<br />

• Increased complexity<br />

• New oxygenators/filters<br />

• Remote pump<br />

Koster A, et al A new m<strong>in</strong>iaturized cardiopulmonary bypass system reduces transfusion<br />

requirements….<br />

J Thorac Cardiovasc Surg. 2009 Jun;137(6):1565-8. Epub 2008 Aug 16.<br />

Miyaji K, et al. The <strong>in</strong>fluences of red blood cell transfusion on perioperative <strong>in</strong>flammatory<br />

responses…<br />

Int Heart J. 2009 Sep;50(5):581-9.<br />

Golab HD, Bogers JJ. Small, smaller, smallest….<br />

Perfusion. 2009 Jul;24(4):239-42. Epub 2009 Oct 20.<br />

Dur<strong>and</strong>y Y. The impact of vacuum-assisted venous dra<strong>in</strong>age <strong>and</strong> m<strong>in</strong>iaturized bypass circuits…<br />

ASAIO J. 2009 Jan-Feb;55(1):117-20.


No Transfusion<br />

• Not often….it is heart surgery after all!!<br />

• 13 neonates 1.7-4kg<br />

• 11/13 transfused but only 2/13 given platelets<br />

Koster et al JTCVS<br />

2009 137(6):1565-8.<br />

• Delayed RBC transfusion reduces <strong>in</strong>flammatory markers<br />

• CRP<br />

• Neutrophils<br />

• Body water ga<strong>in</strong> Myaji et al, Int Heart J.<br />

2009 50(5):581-9.


No Intra-operative ti transfusion:<br />

• Prime volume 110mL<br />

• VAD<br />

• Acceptable Hgb 7g/dL dur<strong>in</strong>g CPB<br />

• NIRS<br />

• 6/13 neonates had no perioperative transfusion<br />

• All corrective procedures (TGA, HAA, IAA, TAPVD)<br />

Koster et al JTCVS 2009 137(6):1565-8.<br />

1565


Delayed Transfusion<br />

• 54 patients 4-10kg<br />

• 41% received RBC transfusion (leucocyte depleted)<br />

• Weight<br />

• CPB time<br />

• NIRS <strong>and</strong> rSO2 <strong>and</strong> SVO2 plus lactate<br />

t<br />

• No platelets or FFP adm<strong>in</strong>istered<br />

• Elevated cRP <strong>and</strong> WCC <strong>in</strong> patients transfused on bypass<br />

Myaji et al. (Int Heart J 2009; 50: 581-589) 589)


Asangu<strong>in</strong>ous Prime<br />

• Composition<br />

i<br />

• Crystalloid Prime<br />

• What solution<br />

• Colloid<br />

• Album<strong>in</strong><br />

• Starch


Hypertonic Hyperoncotic Solutions<br />

Improve Cardiac Function<br />

• Post CPB s<strong>in</strong>gle <strong>in</strong>fusion i of 6% HES vs 0.9%NaCl 4ml/kg<br />

• Increased CI<br />

• Decreased SVRI<br />

• Decreased extravascular lung water<br />

Pediatrics. 2006 Jul;118(1):e76-84. Epub 2006 Jun 2.<br />

Schroth M, et al


High Colloid Pressure is helpful<br />

dur<strong>in</strong>g CPB<br />

• 25% album<strong>in</strong> vs FFP<br />

• Improved hemofiltration rates<br />

• Decreased weight ga<strong>in</strong><br />

• Comparable effects on renal function


Loeffelbe<strong>in</strong> F. et al.; Eur J Cardiothorac Surg 2008;34:648-652<br />

652


In Summary<br />

• <strong>Cardiopulmonary</strong> prime solutions are partly driven by<br />

technological limitations.<br />

• The ideal CPB prime is probably an<br />

• asangu<strong>in</strong>ous<br />

• low volume<br />

• high colloid osmotic pressure solution<br />

• The freshest blood possible should be acquired


Look<strong>in</strong>g <strong>in</strong>to the far() distance…<br />

Therapeutic qu<strong>and</strong>aries:<br />

RIPC<br />

Superhydrophobic surfaces<br />

Bonded circuits<br />

Endothelium

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!